FindTrial
Sign In

To evaluate if Procalcitonin and C- reactive protein can be used to predict mortality in sepsis patients with Cancer.

Evaluation of Procalcitonin and C-Reactive Protein as a prognostic marker among Sepsis patients in Oncology ICU - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094403
Enrollment
153
Registered
2025-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B968- Other specified bacterial agents as the cause of diseases classified elsewhere

Interventions

Intervention1: NIL: NIL

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Sequential organ failure assessment score more than or equal to 2

Exclusion criteria

Exclusion criteria: 1.Refusal for participation in the study 2.Autoimmune diseases 3.Postoperative patients (upto postoperative day 3) 3.Recent Myocardial Infection 4.Pregnant patients

Design outcomes

Primary

MeasureTime frame
Mortality at Day 28 from the inclusion of studyTimepoint: Mortality at 28 th day from the inclusion of study—

Secondary

MeasureTime frame
Duration of ICU stay from the day of inclusion in the study to discharge/death SOFA score at Day 0 ,2 & 4 from the day of inclusion in the studyTimepoint: During the course of ICU stay—

Countries

India

Contacts

Public ContactDr. Shweta Bhopale

All India Institute of Medical Science

dr.shwetabhopale06@gmail.com8178188976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026